期刊文献+

老年黄斑变性患者药物治疗后应用病案管理系统随访的效果分析 被引量:5

The effect of follow-up using medical records management system on patients with age-related macular degeneration
下载PDF
导出
摘要 目的分析随访对老年黄斑变性(age-related macular degeneration,AMD)患者行玻璃体腔内注射抗血管内皮生长因子药物治疗的效果。方法选取2013年1月-2014年12月接受玻璃体腔内注射抗血管内皮生长因子治疗的AMD患者100例,以随机数字表法分为对照组和观察组各50例。对照组在患者每次返院复查时进行健康指导。观察组由专科护理人员利用病案管理系统进行复诊通知、患者评价、病情跟踪、健康指导等。比较2组患者治疗效果、失访率、复发率、视力上升情况、焦虑和抑郁情况及患者满意度。结果观察组治疗的总有效率为94.00%,显著高于对照组的80.00%。观察组在复查期间的失访率及复发率低于对照组,而视力上升的患者比例大于对照组。治疗后,观察组的焦虑、抑郁评分显著低于对照组,患者满意度98.00%显著高于对照组的80.00%。结论对老年黄斑变性患者药物治疗后应用病案管理系统随访,能有效缓解患者的心理压力,保证治疗效果,提高患者的满意度。 Objective To explore the effect of follow-up using medical records management system on patients with age-related macular degeneration(AMD)after injecting vascular endothelial growth factor(VEGF)into the vitreous cavity.Methods A total of 100 AMD patients treated from January 2013 to December 2014 in our hospital were randomly divided into an observation group and a control group,each of 50,according to a random number table.For their follow-up visits,the control group was given health guidance,while the observation group was provided with subsequent visits' notices,patients' evaluation,illness tracking and health guidance using medical records management system.The treatment effect,lost rate,recurrence rate,visual acuity,anxious,depression and patients' satisfaction of 2groups were compared.Results The effectiveness rate of the observation group was 94%,significantly higher than the control group of 80%.In the observation group,the rate of missing follow-up and the recurrence rate were significantly lower than those of the control group,while the visual acuity of the former increased significantly more than the latter group.After treatment,the anxious and depression scores of the observation group were significantly lower than those in the control group.The satisfaction of the observation group reached98%,significantly higher than the control group of 80%.Conclusion The follow-up using medical record management system can alleviate patients' psychological pressure effectively,so as to ensure the treating effect and promote their satisfaction.
出处 《中国临床护理》 2016年第3期257-260,共4页 Chinese Clinical Nursing
基金 深圳市知识创新计划基础研究项目(编号:20150311100031)
关键词 黄斑变性 内皮生长因子 焦虑 抑郁 病案管理系统 Macular degeneration Vascular endothelial growth factor Anxiety Depression Medical record management system
  • 相关文献

参考文献12

二级参考文献213

  • 1王滨,徐辉,曹贵文,孙业全,于德新,宁厚法.肝动脉化疗栓塞对肝癌肿瘤新生血管生成及血管内皮细胞生长因子表达的影响[J].中华放射学杂志,2005,39(2):204-206. 被引量:59
  • 2邹海东,张晳,许迅,汪枫桦,张世杰.上海市静安区曹家渡街道年龄相关性黄斑变性的患病率调查[J].中华眼科杂志,2005,4(1):15-19. 被引量:107
  • 3马敏旺,陈松.老年性黄斑变性流行病学研究进展[J].中华眼底病杂志,2006,22(5):357-360. 被引量:26
  • 4李勇华,侯健,王东星,傅卫军,袁振刚,陈玉宝.含沙利度胺方案治疗多发性骨髓瘤11O例临床分析[J].国际输血及血液学杂志,2007,30(4):300-304. 被引量:5
  • 5Richadson PG, Schlossman R, Hideshima T, et al. New treat ments For multiple myeloma[J]. Oncology (Williston Park), 2005, 19(14) :1781-1792.
  • 6Rajkumar SV, Blood E, Vesole D, et al. Phase HI clinical trial of thalidomide plus dexamethasone compared with dexametha- sone alone in newly diagnosed multiple myeloma~ A clinical trial coordinated by the Eastern Cooperative Oncology Group[J]. J Clin Oncol, 2006, 24(3):431-436.
  • 7Singhal S, Mehta J, Desikan R, et al. itumoractivity0flthalidomidein ref factory multiple myeloma[J]. N Eng IJ Med, 1999,341 (21) : 1565-1571.
  • 8Davies FE, Raje N, Hideshima T, et al. Thalidomide and im- munomodulatory derivatives augment natural killer cell cytotox- icity in multiple myeloma[J]. Blood, 2001, 98(1):210-216.
  • 9Mileshkin L, Honemann D, Gambell P, et al. Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, eytokines, angiogenic markers, mast cells and marrow CD57 + cy- totoxic T cells as predictors of outcome[J]. Haematologiea, 2007,92 (8) : 1075-1082.
  • 10de Jong PT. Age-related maeular degeneration. N Engl J Med, 2006,355: 1474-1485.

共引文献206

同被引文献55

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部